The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 22, 2019

Filed:

Nov. 21, 2017
Applicant:

Bayer Aktiengesellschaft, Leverkusen, DE;

Inventors:

Adam James Davenport, Abingdon, GB;

Nico Bräuer, Falkensee, DE;

Oliver Martin Fischer, Berlin, DE;

Andrea Rotgeri, Berlin, DE;

Antje Rottmann, Berlin, DE;

Ioana Neagoe, Hamburg, DE;

Jens Nagel, Daxweiler, DE;

Anne-Marie Godinho-Coelho, Hamburg, DE;

Jürgen Klar, Wuppertal, DE;

Assignee:

Bayer Aktiengesellschaft, Leverkusen, DE;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C07D 417/12 (2006.01); C07D 417/14 (2006.01); C07D 471/08 (2006.01); A61P 31/18 (2006.01); A61P 25/16 (2006.01); A61P 13/00 (2006.01); A61P 29/00 (2006.01); A61P 25/28 (2006.01); A61K 31/4439 (2006.01); A61K 31/497 (2006.01); A61K 31/501 (2006.01); A61K 31/506 (2006.01); A61K 31/433 (2006.01);
U.S. Cl.
CPC ...
C07D 417/14 (2013.01); C07D 417/12 (2013.01); C07D 471/08 (2013.01);
Abstract

The present invention relates to 1,3-thiazol-2-yl substituted benzamide compounds of general formula (I) as described and defined herein, to pharmaceutical compositions and combinations comprising said compounds and to the use of said compounds for manufacturing a pharmaceutical composition for the treatment or prophylaxis of a disease, in particular of neurogenic disorder, as a sole agent or in combination with other active ingredients.


Find Patent Forward Citations

Loading…